Literature DB >> 18316379

Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors.

Eric T Harvill1, Manuel Osorio, Crystal L Loving, Gloria M Lee, Vanessa K Kelly, Tod J Merkel.   

Abstract

The threat of bioterrorist use of Bacillus anthracis has focused urgent attention on the efficacy and mechanisms of protective immunity induced by available vaccines. However, the mechanisms of infection-induced immunity have been less well studied and defined. We used a combination of complement depletion along with immunodeficient mice and adoptive transfer approaches to determine the mechanisms of infection-induced protective immunity to B. anthracis. B- or T-cell-deficient mice lacked the complete anamnestic protection observed in immunocompetent mice. In addition, T-cell-deficient mice generated poor antibody titers but were protected by the adoptive transfer of serum from B. anthracis-challenged mice. Adoptively transferred sera were protective in mice lacking complement, Fc receptors, or both, suggesting that they operate independent of these effectors. Together, these results indicate that antibody-mediated neutralization provides significant protection in B. anthracis infection-induced immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316379      PMCID: PMC2346704          DOI: 10.1128/IAI.00647-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  Introduction: anthrax history, disease and ecology.

Authors:  P C B Turnbull
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Authors:  E D Williamson; I Hodgson; N J Walker; A W Topping; M G Duchars; J M Mott; J Estep; C Lebutt; H C Flick-Smith; H E Jones; H Li; C P Quinn
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo.

Authors:  Jason E Comer; Ashok K Chopra; Johnny W Peterson; Rolf König
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Authors:  Jargalsaikhan Enkhtuya; Keiko Kawamoto; Yoshiyasu Kobayashi; Ikuo Uchida; Neeraj Rana; Sou-ichi Makino
Journal:  Microbiology       Date:  2006-10       Impact factor: 2.777

6.  Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.

Authors:  S F Little; B E Ivins; P F Fellows; A M Friedlander
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis.

Authors:  Ian Justin Glomski; Jean-Philippe Corre; Michèle Mock; Pierre Louis Goossens
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis.

Authors:  I Uchida; J M Hornung; C B Thorne; K R Klimpel; S H Leppla
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

Review 9.  2001: a year of major advances in anthrax toxin research.

Authors:  Michael Mourez; D Borden Lacy; Kristina Cunningham; Rachel Legmann; Bret R Sellman; Jeremy Mogridge; R John Collier
Journal:  Trends Microbiol       Date:  2002-06       Impact factor: 17.079

10.  A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

Authors:  K H Mills; M Ryan; E Ryan; B P Mahon
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

View more
  6 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

2.  Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG.

Authors:  Guoquan Zhang; Ying Peng; Laura Schoenlaub; Alexandra Elliott; William Mitchell; Yan Zhang
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

3.  Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments.

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Toxicon       Date:  2013-04-17       Impact factor: 3.033

Review 4.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

5.  A requirement for FcγR in antibody-mediated bacterial toxin neutralization.

Authors:  Nareen Abboud; Siu-Kei Chow; Carolyn Saylor; Alena Janda; Jeffery V Ravetch; Matthew D Scharff; Arturo Casadevall
Journal:  J Exp Med       Date:  2010-10-04       Impact factor: 14.307

6.  An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8+ T Cells.

Authors:  Brett Palaschak; Damien Marsic; Roland W Herzog; Sergei Zolotukhin; David M Markusic
Journal:  Mol Ther Methods Clin Dev       Date:  2017-04-19       Impact factor: 6.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.